Management in attendance: Kiran Mazumdar Shaw and Senior Management Team
Conference Call with Biocon Management and Analysts on Q3FY22 Performance and Outlook. Listen to the full earnings transcript.
Conference Call with Biocon Management and Analysts on the new Biocon SILS collaboration. Click on the pdf to read the full transcript.
Management in attendance: Kiran Mazumdar Shaw, Adar Poonawalla.
Conference Call with Management from Biocon (Kiran Mazumdar Shaw) and Serum Institute (Adar Poonawalla) on the strategic alliance between Biocon Biologics and Serum Institute subsidiary Covidshield Technologies. Listen to the full transcript.
Conference Call with Biocon Management and Analysts on Q2FY21 Performance and Outlook. Listen to the full earnings transcript.
